Your Health, We Care
Repotrectinib is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).
from FDA，2023.11
Detailed Indications for RepotrectinibOne core indication of Repotrectinib is th···【more】
Release date：2026-06-03Recommended：47
What is Repotrectinib?Repotrectinib (generic name: repotrectinib) is an oral pre···【more】
Release date：2026-06-01Recommended：55
Adult patients with locally advanced or metastatic ROS1 positive non-small cell ···【more】
Release date：2026-01-05Recommended：38
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
